Meetings & Events

Thyroid Cancer Overdiagnosis

June 18, 2021

Session Date and Time:

Sunday, September 12
12:00–12:45 PM EDT

Learning Objectives:

  1. Describe the evolving epidemiology of thyroid cancer in the U.S.
  2. Summarize the different interpretations of the data.
  3. Evaluate the evidence supporting different explanations.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Julie Ann Sosa, MD, MADr. Sosa is the Leon Goldman, MD, Distinguished Professor of Surgery and Chair of the Department of Surgery at the University of California San Francisco (UCSF), where she is also a Professor in the Department of Medicine and affiliated faculty for the Philip R. Lee Institute for Health Policy Studies. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer.

She is an NIH- and FDA-funded investigator and author of more than 340 peer-reviewed publications and 80 book chapters and reviews, all largely focused on outcomes research, health care delivery, hyperparathyroidism, and thyroid cancer, with a focus on clinical trials. She has authored or edited seven books.

Dr. Sosa is Treasurer of the American Thyroid Association (ATA) and serves on the Board of Directors/Executive Council of the ATA and International Thyroid Oncology Group, as well as practice guidelines committees for the ATA, NCCN, and the American Association of Endocrine Surgeons; for the ATA, she is chairing the committee responsible for writing the next iteration of differentiated thyroid cancer guidelines. She is the Editor-in-Chief of the World Journal of Surgery.

Dr. Sosa was born in Montreal and raised in upstate New York. She received her AB at Princeton, MA at Oxford, and MD at Johns Hopkins, where she completed the Halsted residency and a fellowship.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.